The Patent Finder

Merck Sharp Dohme Corp.

Also on record
Records under this name other than the patents Merck Sharp Dohme Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 8 of 8 · Back to Merck Sharp Dohme Corp.

PatentTitleStatus Expires Confidence
US 8,557,992Heterocyclic Fused Phenanthrolinone M1 Receptor Positive Allosteric Modulators
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,304,094Novel Cyclohexyl Sulphones
Term ended
Term ended Sep 20, 2022 · High confidence
Term endedTerm ended Sep 20, 2022High confidence
US 8,518,975Gamma Secretase Modulators
Lapsed on the fee record
Ended Aug 27, 2017 · High confidence
Lapsed on the fee recordEnded Aug 27, 2017High confidence
US 8,293,731HIV Integrase Inhibitors
Lapsed on the fee record
Ended Oct 23, 2016 · High confidence
Lapsed on the fee recordEnded Oct 23, 2016High confidence
US 8,222,418Piperidines and Related Compounds for the Treatment of Dementia
Lapsed on the fee record
Ended Jul 17, 2016 · High confidence
Lapsed on the fee recordEnded Jul 17, 2016High confidence
US 7,300,955Method and Materials for Treatment of Alzheimer's Disease
Lapsed on the fee record
Ended Nov 27, 2015 · High confidence
Lapsed on the fee recordEnded Nov 27, 2015High confidence
US 5,254,561Tricyclic antipsychotic agents
Formerly held
Term ended
Term ended no later than Oct 19, 2013 · Low confidence
Term endedTerm ended no later than Oct 19, 2013Low confidence
US 5,612,337Substituted morpholine derivatives and their use as therapeutic agents
Term ended
Term ended no later than Mar 18, 2017 · Low confidence
Term endedTerm ended no later than Mar 18, 2017Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited